Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.

about

Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.

Item

http://www.wikidata.org/entity/Q47564590

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effectiveness and tolerability ...... imab for mantle cell lymphoma.

@en

Effectiveness and tolerability ...... imab for mantle cell lymphoma.

@nl

type

Item

label

Effectiveness and tolerability ...... imab for mantle cell lymphoma.

@en

Effectiveness and tolerability ...... imab for mantle cell lymphoma.

@nl

prefLabel

Effectiveness and tolerability ...... imab for mantle cell lymphoma.

@en

Effectiveness and tolerability ...... imab for mantle cell lymphoma.

@nl

P1476

Effectiveness and tolerability ...... imab for mantle cell lymphoma.

@en

P2093

Haiyan Jiang

http://www.w3.org/2001/XMLSchema#string

John Kuruvilla

http://www.w3.org/2001/XMLSchema#string

Michael Crump

http://www.w3.org/2001/XMLSchema#string

Shaheena Bashir

http://www.w3.org/2001/XMLSchema#string

Umberto Falcone

http://www.w3.org/2001/XMLSchema#string

Vishal Kukreti

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries.

Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?

Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.

P2888

s41409-017-0054-8

P304

347-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41409-017-0054-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Richard W. Tsang

Armand Keating

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099735708

http://www.w3.org/2001/XMLSchema#string

P698

29269808

http://www.w3.org/2001/XMLSchema#string